社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Crinetics Pharmaceuticals Inc.(CRNX)
盘后
83.45
-0.04
-0.05%
19:59 EDT
83.49
-0.04
-0.05%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
公司概况
公司名称
Crinetics Pharmaceuticals Inc.
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.crinetics.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Crinetics Pharmaceuticals, Inc.于2008年11月18日根据特拉华州法律注册成立。该公司是一家临床阶段制药公司，致力于发现，开发和商业化用于治疗罕见内分泌疾病和内分泌相关肿瘤的新药。 内分泌途径的功能是保持体内平衡，并且通常使用通过G蛋白偶联受体或GPCRs起作用的肽激素来调节生理学的许多方面，包括生长，能量，代谢，胃肠功能和应激反应。
07-06
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
07-03
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
07-03
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
06-22
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
06-17
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
05-15
超过5%披露
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
05-15
超过5%披露
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
05-15
超过5%披露
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
05-08
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05-08
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-04
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
04-29
超过5%披露
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
04-14
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
04-14
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
04-10
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
分时
5日
日
周
月
数据加载中...
最高
83.57
今开
83.52
量比
0.99
最低
83.44
昨收
83.53
换手率
18.72%
热议股票
{"pagemeta":{"title":"Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Crinetics Pharmaceuticals Inc.(CRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Crinetics Pharmaceuticals Inc.,CRNX,Crinetics Pharmaceuticals Inc.股票,Crinetics Pharmaceuticals Inc.股票老虎,Crinetics Pharmaceuticals Inc.股票老虎国际,Crinetics Pharmaceuticals Inc.行情,Crinetics Pharmaceuticals Inc.股票行情,Crinetics Pharmaceuticals Inc.股价,Crinetics Pharmaceuticals Inc.股市,Crinetics Pharmaceuticals Inc.股票价格,Crinetics Pharmaceuticals Inc.股票交易,Crinetics Pharmaceuticals Inc.股票购买,Crinetics Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Crinetics Pharmaceuticals Inc.(CRNX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Crinetics Pharmaceuticals Inc.(CRNX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"CRNX","data":{"stockData":{"symbol":"CRNX","market":"US","secType":"STK","nameCN":"Crinetics Pharmaceuticals Inc.","latestPrice":83.49,"timestamp":1783540800000,"preClose":83.53,"halted":0,"volume":17889929,"hourTrading":{"tag":"盘后","latestPrice":83.45,"preClose":83.49,"latestTime":"19:59 EDT","volume":124917,"amount":10427205.254,"timestamp":1783555179012,"change":-0.04,"changeRate":-0.000479,"amplitude":0.003114},"delay":0,"changeRate":-0.0004788698671136867,"floatShares":95543500,"shares":105439535,"eps":-5.129138,"marketStatus":"未开盘","change":-0.04,"latestTime":"07-08 16:00:00 EDT","open":83.52,"high":83.57,"low":83.44,"amount":1493736438.3882601,"amplitude":0.001556,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.129138,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783584000000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1531886400000,"exchange":"NASDAQ","adjPreClose":83.53,"preHourTrading":{"tag":"盘前","latestPrice":83.56,"preClose":83.53,"latestTime":"09:29 EDT","volume":33311,"amount":2782043.7809699997,"timestamp":1783517399999,"change":0.03,"changeRate":0.000359,"amplitude":0.014823},"postHourTrading":{"tag":"盘后","latestPrice":83.45,"preClose":83.49,"latestTime":"19:59 EDT","volume":124917,"amount":10427205.254,"timestamp":1783555179012,"change":-0.04,"changeRate":-0.000479,"amplitude":0.003114},"volumeRatio":0.989043,"impliedVol":0.3419,"impliedVolPercentile":0.1394},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"21476889","market":"us","labels":[],"media":"sec.gov","original_id":"AN114036126027642-CRNX","pdf_url":"","pub_time":1783310400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"CRNX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/000114036126027642/0001140361-26-027642-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 2.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000114036126027642/ef20077399_ex2-1.htm","primary":true,"translateUrl":"","linkName":"ef20077399_ex2-1.htm","type":"EX-2.1","id":"NTFILE763pcMYTsipYk5RU","market":"us","size":669368},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000114036126027642/ef20077399_form8k.htm","primary":false,"translateUrl":"","linkName":"ef20077399_form8k.htm","type":"8-K","id":"NTFILE395dfYAYhE9K6h4N","market":"us","size":59123},{"description":"EXHIBIT 99.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000114036126027642/ef20077399_ex99-1.htm","primary":false,"translateUrl":"","linkName":"ef20077399_ex99-1.htm","type":"EX-99.1","id":"NTFILEDtxNnpxqtd6VZ8bo","market":"us","size":53716}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-07-06 12:00","pubTimestamp":1783310400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21468427","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726006832-CRNX","pdf_url":"","pub_time":1783024311000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"CRNX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/0001950047-26-006832-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000195004726006832/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEh7GqS3R2Cwww98YP","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-07-03 04:31","pubTimestamp":1783024311,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21468404","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726006823-CRNX","pdf_url":"","pub_time":1783024170000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"CRNX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/0001950047-26-006823-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1610381/000195004726006823/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEFYaymtZcFEBDWy77","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-07-03 04:29","pubTimestamp":1783024170,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21418325","market":"us","labels":[],"media":"sec.gov","original_id":"AN165824726000044-CRNX","pdf_url":"","pub_time":1782100800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"CRNX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000044/0001658247-26-000044-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000044/crnx-20260618.htm","primary":true,"translateUrl":"","linkName":"crnx-20260618.htm","type":"8-K","id":"NTFILE7EPpVT8dc7Av3J7K","market":"us","size":34078}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-06-22 12:00","pubTimestamp":1782100800,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"项目5.07：将事项提交证券持有人表决","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21407266","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726006257-CRNX","pdf_url":"","pub_time":1781668800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"CRNX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/000195004726006257/0001950047-26-006257-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000195004726006257/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEFq2QE1wzCQXAD32B","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-06-17 12:00","pubTimestamp":1781668800,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21267438","market":"us","labels":[],"media":"sec.gov","original_id":"AN8025526000423-CRNX","pdf_url":"","pub_time":1778817600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"CRNX","title":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/000008025526000423/0000080255-26-000423-index.htm","us_notice_code":"Form SCHEDULE 13G/A","us_title_en":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/80255/000008025526000423/xslSCHEDULE_13G_X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"SCHEDULE 13G/A","id":"NTFILEJ7XouL8FM4RT3KTx","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2026-05-15 12:00","pubTimestamp":1778817600,"title_zh":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21266064","market":"us","labels":[],"media":"sec.gov","original_id":"AN90221926000169-CRNX","pdf_url":"","pub_time":1778817600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"CRNX","title":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/000090221926000169/0000902219-26-000169-index.htm","us_notice_code":"Form SCHEDULE 13G/A","us_title_en":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/902219/000090221926000169/xslSCHEDULE_13G_X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"SCHEDULE 13G/A","id":"NTFILEH4AfSj4oriY8zzCD","market":"us","size":0},{"description":"JOINT FILING AGREEMENT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/902219/000090221926000169/Rule13D_JointFilingAgreement.htm","primary":false,"translateUrl":"","linkName":"Rule13D_JointFilingAgreement.htm","type":"EX-99","id":"NTFILEC8QPEWHqoga1gr36","market":"us","size":4415}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2026-05-15 12:00","pubTimestamp":1778817600,"title_zh":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21265591","market":"us","labels":[],"media":"sec.gov","original_id":"AN93820626000029-CRNX","pdf_url":"","pub_time":1778817600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","symbol":"CRNX","title":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/000093820626000029/0000938206-26-000029-index.htm","us_notice_code":"Form SCHEDULE 13G/A","us_title_en":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/938206/000093820626000029/xslSCHEDULE_13G_X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"SCHEDULE 13G/A","id":"NTFILEEPCDdCStLcQ1KGpn","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2026-05-15 12:00","pubTimestamp":1778817600,"title_zh":"Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21227994","market":"us","labels":[],"media":"sec.gov","original_id":"AN165824726000040-CRNX","pdf_url":"","pub_time":1778185276000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"CRNX","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/1658247/0001658247-26-000040-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000040/crnx-20260331.htm","primary":true,"translateUrl":"","linkName":"crnx-20260331.htm","type":"10-Q","id":"NTFILE5s83aWe5iEzeirjj","market":"us","size":925273},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000040/crnx-20260331xex311.htm","primary":false,"translateUrl":"","linkName":"crnx-20260331xex311.htm","type":"EX-31.1","id":"NTFILE8cM1pxdkfVvJadkF","market":"us","size":9762},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000040/crnx-20260331xex312.htm","primary":false,"translateUrl":"","linkName":"crnx-20260331xex312.htm","type":"EX-31.2","id":"NTFILE8qVGbU9aMairBRyr","market":"us","size":9699},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000040/crnx-20260331xex321.htm","primary":false,"translateUrl":"","linkName":"crnx-20260331xex321.htm","type":"EX-32.1","id":"NTFILEUWHPqwoJ8FpeNsgZ","market":"us","size":6963}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2026-05-08 04:21","pubTimestamp":1778185276,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21228014","market":"us","labels":[],"media":"sec.gov","original_id":"AN165824726000039-CRNX","pdf_url":"","pub_time":1778184970000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"CRNX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/0001658247-26-000039-index.html","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000039/crnxq126earningspr.htm","primary":true,"translateUrl":"","linkName":"crnxq126earningspr.htm","type":"EX-99.1","id":"NTFILEGR7KNdidUtkGRxeT","market":"us","size":100328},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000039/crnx-20260507.htm","primary":false,"translateUrl":"","linkName":"crnx-20260507.htm","type":"8-K","id":"NTFILE7BqSCRJUzTcD8fAv","market":"us","size":25714},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000039/image_0.jpg","primary":false,"translateUrl":"","linkName":"image_0.jpg","type":"GRAPHIC","id":"NTFILEEGMWh9Phoh8jWYmS","market":"us","size":56061}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-05-08 04:16","pubTimestamp":1778184970,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目2.02：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21207634","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726003982-CRNX","pdf_url":"","pub_time":1777867200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"CRNX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/000195004726003982/0001950047-26-003982-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000195004726003982/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEAPWA8GcdWZHEaJYp","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-05-04 12:00","pubTimestamp":1777867200,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21190520","market":"us","labels":[],"media":"sec.gov","original_id":"AN210011926000284-CRNX","pdf_url":"","pub_time":1777435200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors","symbol":"CRNX","title":"Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors","titleType":"超过5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/000210011926000284/0002100119-26-000284-index.htm","us_notice_code":"Form SCHEDULE 13G","us_title_en":"Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000210011926000284/xslSCHEDULE_13G_X02/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"SCHEDULE 13G","id":"NTFILEGSyTMNKKdHbh4yqD","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超过5%披露","pubTime":"2026-04-29 12:00","pubTimestamp":1777435200,"title_zh":"Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21001454","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726003450-CRNX","pdf_url":"","pub_time":1776139200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"CRNX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/000195004726003450/0001950047-26-003450-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000195004726003450/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE8aq4WvUcySD6uS7X","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-04-14 12:00","pubTimestamp":1776139200,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20995469","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726003400-CRNX","pdf_url":"","pub_time":1776112616000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"CRNX","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/0001950047-26-003400-index.html","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000195004726003400/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE82ZbsAXqfjCxo6fo","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-04-14 04:36","pubTimestamp":1776112616,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20987991","market":"us","labels":[],"media":"sec.gov","original_id":"AN165824726000022-CRNX","pdf_url":"","pub_time":1775793600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"CRNX","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000022/0001658247-26-000022-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EX-10.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000022/crinetics-finalconsultanta.htm","primary":true,"translateUrl":"","linkName":"crinetics-finalconsultanta.htm","type":"EX-10.1","id":"NTFILE5ewVfiMmj4VHuL9j","market":"us","size":83679},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000022/crnx-20260410.htm","primary":false,"translateUrl":"","linkName":"crnx-20260410.htm","type":"8-K","id":"NTFILEv3jDiRXvXjSzPgPj","market":"us","size":27414},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1658247/000165824726000022/image_0.jpg","primary":false,"translateUrl":"","linkName":"image_0.jpg","type":"GRAPHIC","id":"NTFILEHB6y4m23YZxM7Zei","market":"us","size":54050}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-04-10 12:00","pubTimestamp":1775793600,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第5.02项：董事或某些高级职员的离职；选举董事；若干人员的委任：若干人员的补偿安排；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.crinetics.com","stockEarnings":[{"period":"1week","weight":1.1585},{"period":"1month","weight":1.4937},{"period":"3month","weight":1.1067},{"period":"6month","weight":0.5679},{"period":"1year","weight":1.8427},{"period":"ytd","weight":0.7936}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0084},{"period":"3month","weight":0.0963},{"period":"6month","weight":0.074},{"period":"1year","weight":0.2016},{"period":"ytd","weight":0.0931}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Crinetics Pharmaceuticals, Inc.于2008年11月18日根据特拉华州法律注册成立。该公司是一家临床阶段制药公司，致力于发现，开发和商业化用于治疗罕见内分泌疾病和内分泌相关肿瘤的新药。 内分泌途径的功能是保持体内平衡，并且通常使用通过G蛋白偶联受体或GPCRs起作用的肽激素来调节生理学的许多方面，包括生长，能量，代谢，胃肠功能和应激反应。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.078473},{"month":2,"riseRate":0.5,"avgChangeRate":-0.021565},{"month":3,"riseRate":0.25,"avgChangeRate":-0.056934},{"month":4,"riseRate":0.625,"avgChangeRate":0.06869},{"month":5,"riseRate":0.5,"avgChangeRate":-0.026047},{"month":6,"riseRate":0.625,"avgChangeRate":0.005036},{"month":7,"riseRate":0.5,"avgChangeRate":0.131615},{"month":8,"riseRate":0.5,"avgChangeRate":0.05546},{"month":9,"riseRate":0.375,"avgChangeRate":0.104829},{"month":10,"riseRate":0.5,"avgChangeRate":0.007484},{"month":11,"riseRate":0.875,"avgChangeRate":0.104868},{"month":12,"riseRate":0.75,"avgChangeRate":0.036899}],"exchange":"NASDAQ","name":"Crinetics Pharmaceuticals Inc.","nameEN":"Crinetics Pharmaceuticals Inc."},"aProfile":null}}}